全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Coexistence of Ankylosing Spondylitis and L?fgren’s Syndrome

DOI: 10.1155/2014/747698

Full-Text   Cite this paper   Add to My Lib

Abstract:

A 46-year-old male patient diagnosed with ankylosing spondylitis presented to our polyclinic with complaints of pain, swelling, and limitation in joint mobility in both ankles and erythema nodosum skin lesions in both pretibial sites. The sacroiliac joint graphy and the MRI taken revealed active and chronic sacroiliitis. On the thorax CT, multiple mediastinal and hilar lymphadenopathies were reported. Mediastinoscopic excisional lymph node biopsy was taken and noncalcified granulomatous structures, lymphocytes, and histiocytes were determined on histopathological examination. The patients were diagnosed with ankylosing spondylitis, sarcoidosis, and L?fgren’s syndrome. NSAIDs, sulfasalazine, and low dose corticosteroid were started. Significant regression was seen in the patient’s subjective and laboratory assessments. 1. Introduction Sarcoidosis is a systemic disease characterized by the involvement of multiple tissues and organs and a noncalcified granulomatous reaction, which is not well understood [1]. L?fgren syndrome is an acute sarcoidosis presentation characterized by arthritis/arthralgia, erythema nodosum (EN), and bilateral hilar lymphadenopathy. Although its pathogenesis in not clear, there appears to be a cellular immune system activation and a nonspecific inflammatory response against some genetic and environmental factors [2]. Th1-lymphocyte and macrophages caused by proinflammatory cytokines induce the inflammatory cascade and the formations of granulomas occur as a result of tissue permeability, cellular influx, and local cell proliferation [3]. The indispensable pathological finding of sarcoidosis is noncalcified epitheloid cellular granulomas [4]. Different prevalence, clinical findings, and course of disease in different races and ethnic groups suggest that sarcoidosis is a heterogeneous disease [5]. The disease is more prevalent in women and develops after 40 years of age. Sarcoidosis is a chronic granulomatous disease that may present with different clinical findings. The disease most frequently presents with bilateral hilar lymphadenopathy, infiltrations in the lungs, and skin and eye lesions. It may mimic a number of primary rheumatic diseases (connective tissue diseases, vasculitis, and spondyloarthritis) and/or develop concomitantly to these [6]. Locomotor involvement is determined to be 15–25%. The sacroiliac joint involvement typical in ankylosing spondylitis (AS) is rarely observed in sarcoidosis. In this paper, we report a case of ankylosing spondylitis coexisting with L?fgren’s syndrome. 2. Case Report A 46-year-old male

References

[1]  L. S. Newman, C. S. Rose, and L. A. Maier, “Sarcoidosis,” The New England Journal of Medicine, vol. 336, no. 17, pp. 1224–1234, 1997.
[2]  E. S. Chen and D. R. Moller, “Etiology of sarcoidosis,” Clinics in Chest Medicine, vol. 29, no. 3, pp. 365–377, 2008.
[3]  G. Smith, I. Brownell, M. Sanchez, and S. Prystowsky, “Advances in the genetics of sarcoidosis,” Clinical Genetics, vol. 73, pp. 401–412, 2008.
[4]  Y. P. Kataria and J. F. Holter, “Immunology of sarcoidosis,” Clinics in Chest Medicine, vol. 18, no. 4, pp. 719–739, 1997.
[5]  B. A. Rybicki, M. Major, J. Popovich Jr., M. J. Maliarik, and M. C. Iannuzzi, “Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization,” American Journal of Epidemiology, vol. 145, no. 3, pp. 234–241, 1997.
[6]  T. Pettersson, “Rheumatic features of sarcoidosis,” Current Opinion in Rheumatology, vol. 10, no. 1, pp. 73–78, 1998.
[7]  J. Grunewald and A. Eklund, “L?fgren's syndrome: human leukocyte antigen strongly influences the disease course,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 4, pp. 307–312, 2009.
[8]  P. Kremer, E. Gallinet, A. Benmansour, J. Despaux, E. Toussirot, and D. Wendling, “Sarcoidosis and spondylarthropathy. Three case-reports,” Revue du Rhumatisme, vol. 63, no. 6, pp. 405–411, 1996.
[9]  M. A. Gonzalez-Lopez, R. Blanco, M. Carmen Gonzalez-vela, H. Fernandez-llaca, and V. Rodr?guez-valverde, “Development of sarcoidosis during etanercept therapy,” Arthritis & Rheumatology, vol. 55, pp. 817–820, 2006.
[10]  R. Almodóvar, M. Izquierdo, P. Zarco, F. Javier Quiroós, R. Mazzucchelli, and B. Steen, “Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab,” Clinical and Experimental Rheumatology, vol. 25, no. 1, pp. 99–101, 2007.
[11]  I. Kotter, H. Durk, and J. G. Saal, “Sarcoiliitis in sarcoidosis: case reports and review of the literature,” Clinical Rheumatology, vol. 14, no. 6, pp. 695–700, 1995.
[12]  G. Stucki, A. Von Felten, R. Speich, and B. A. Michel, “Ankylosing spondylitis and sarcoidosis—coincidence or association? Case report and review of the literature,” Clinical Rheumatology, vol. 11, no. 3, pp. 436–439, 1992.
[13]  M. Martinetti, C. Tinelli, V. Kolek et al., “‘The sarcoidosis map’: a joint survey of clinical and immunogenetic findings in two European countries,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 2, pp. 557–564, 1995.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133